Abstract:Importance: Studies report disproportionate increases in cannabis use among middle-aged (50-64) and older (65+) U.S. adults, groups particularly vulnerable to its adverse effects. However, national data on attitudes towards cannabis use and legalization, as well as prevalences of key cannabis-related behaviors are lacking for these groups. Objective: To present national prevalences of past-year any cannabis use, medical use, consumption methods, and other important use-related behaviors, and attitudes toward use, as well as associations of such behaviors and attitudes to cannabis use among U.S. adults ages 50 and older. Design: Cross-sectional data from the Health and Retirement Study (HRS) were used to calculate weighted prevalences for all cannabis measures by primary age groups (50-64, ≥65) as well as two specified older age groups (65-74, ≥75) and sex. Associations between sociodemographics and cannabis use were evaluated using multivariable logistic regression. Main Outcomes and Measures: Self-reported past-year cannabis use (outcome), consumption methods, medical use and health conditions for which cannabis was used, prescriptions by healthcare providers, current and past perception of acceptability, perceptions of risk, and attitudes toward legalization (exposures). Covariates included sex, race/ethnicity, household income, and employment status. Setting and Participants: HRS participants who completed the 2018 cannabis use experimental module (n=1,324). Results: Past year cannabis use was reported by 18.5% (SE=2.17) and 5.9% (SE=1.19) of middle-age and older adults, respectively in the U.S. In both groups, a majority of individuals consumed cannabis exclusively by smoking. Approximately 25% of middle-aged adults and 20% of older adults used cannabis for medical purposes, with ~20% in both groups receiving a prescription or recommendation for medical use from a healthcare provider. Over 75% of individuals in both age groups viewed medical use of cannabis as acceptable, and older adults were more likely to view cannabis as a gateway drug and to support restrictions of cannabis laws. Conclusions and Relevance: Cannabis use among both middle-aged and older U.S. adults is higher than previously reported in state- and national-level studies, with many engaging in cannabis behaviors associated with increased harm. Greater public health and clinical efforts are needed for tailored prevention and intervention strategies.

Prevalence of Blunt and Hemp Wrap Use Among Young Adults in the United States, 2022

Trends in cannabis and tobacco co-use in the United States, 2002-2021

Evolving disparities in cannabis use among youth by demographics, tobacco and alcohol use in the US: 2013-2021

Historical Trends in Cannabis Use among U.S. Adults Aged 19-55, 2013-2021

The many forms of cannabis use: Prevalence and correlates of routes of administration among nationally representative samples of U.S. adult and adolescent cannabis users

Blunt smoking during emerging adulthood: Characterizing transitions in cannabis and cigar co-use among a diverse cohort in Texas

Epidemiology of Cannabis Use Among Middle-Aged and Older Adults in the United States

Outpatient Prescription Cannabinoid Utilisation in the USA: a Population-Based Study.

Changes in Sources of Information about the Risks and Benefits of Cannabis in a National Cohort of US Adults from 2017 - 2021

Cannabis flower, concentrates, and edibles: a narrative review comparing prevalence of use, methods of consumption, and cannabis use disorder outcomes

Cannabis-related information sources among US residents: A probability-weighted nationally representative survey

Prevalence of Cannabis Use Among US Workers in 15 States, 2016–2020

US Epidemiology of Cannabis Use and Associated Problems

Types and Brands of Derived Psychoactive Cannabis Products: An Online Retail Assessment, 2023

Youth and Young Adult Blunt Use Predicts Progression to Other Nicotine Product Use in the United States

Young Adults' Experiences with Cannabis Retailer Marketing and Related Practices: Differences Among Sociodemographic Groups and Associations with Cannabis Use-related Outcomes

Youth Risk Behavior Surveillance System 2021

Intoxicating Cannabis Products in Vape Shops: United States, 2023

Derived psychoactive cannabis product perceptions and use among a sample of US young adults

Reevaluating America's Latest Pharmaceutical Trend: The Cardiovascular Risk of Cannabis

Knowledge and beliefs about blunts among youth in the United States